Viewing Study NCT01442259


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2025-12-29 @ 3:45 PM
Study NCT ID: NCT01442259
Status: COMPLETED
Last Update Posted: 2020-12-08
First Post: 2011-09-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module